Literature DB >> 4330595

Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus.

H W Kim, J O Arrobio, G Pyles, C D Brandt, E Camargo, R M Chanock, R H Parrott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4330595

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  37 in total

1.  The major attenuating mutations of the respiratory syncytial virus vaccine candidate cpts530/1009 specify temperature-sensitive defects in transcription and replication and a non-temperature-sensitive alteration in mRNA termination.

Authors:  K Juhasz; B R Murphy; P L Collins
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 2.  Current research on respiratory viral infections: Third International Symposium.

Authors:  A C Schmidt; R B Couch; G J Galasso; F G Hayden; J Mills; B R Murphy; R M Chanock
Journal:  Antiviral Res       Date:  2001-06       Impact factor: 5.970

3.  The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein.

Authors:  K Juhasz; S S Whitehead; P T Bui; J M Biggs; J E Crowe; C A Boulanger; P L Collins; B R Murphy
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 4.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

5.  Baculovirus expression of the respiratory syncytial virus fusion protein using Trichoplusia ni insect cells.

Authors:  M Parrington; S Cockle; P Wyde; R P Du; E Snell; W Y Yan; Q Wang; L Gisonni; S Sanhueza; M Ewasyshyn; M Klein
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

Review 6.  Viral and host factors in human respiratory syncytial virus pathogenesis.

Authors:  Peter L Collins; Barney S Graham
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

7.  Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzees.

Authors:  S S Whitehead; K Juhasz; C Y Firestone; P L Collins; B R Murphy
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

8.  Acquisition of the ts phenotype by a chemically mutagenized cold-passaged human respiratory syncytial virus vaccine candidate results from the acquisition of a single mutation in the polymerase (L) gene.

Authors:  J E Crowe; C Y Firestone; S S Whitehead; P L Collins; B R Murphy
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

9.  Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus.

Authors:  Y W Tang; B S Graham
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  Class-specific antibodies to bovine respiratory syncytial virus in experimentally infected lambs.

Authors:  R Sharma; Z Woldehiwet
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.